13292-40-5 Usage
Description
(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(piperidin-1-ylamino)methylidene]-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is a complex organic compound characterized by its naphthofuran core structure and a variety of functional groups, including multiple hydroxyl and methyl groups, an epoxide, a piperidin-1-ylamino group, and an acetate functional group. Its intricate structure suggests potential applications in the pharmaceutical or materials science fields.
Uses
Used in Pharmaceutical Industry:
(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(piperidin-1-ylamino)methylidene]-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a potential pharmaceutical agent for its diverse functional groups that may interact with biological targets, potentially leading to the development of new drugs.
Used in Materials Science:
In the field of materials science, (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(piperidin-1-ylamino)methylidene]-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate could be utilized as a component in the development of advanced materials, such as polymers or composites, due to its unique structural features and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 13292-40-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,9 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13292-40:
(7*1)+(6*3)+(5*2)+(4*9)+(3*2)+(2*4)+(1*0)=85
85 % 10 = 5
So 13292-40-5 is a valid CAS Registry Number.
13292-40-5Relevant articles and documents
Synthesis, docking and antibacterial studies of more potent amine and hydrazone rifamycin congeners than rifampicin
Pyta, Krystian,Janas, Anna,Szukowska, Monika,Pecyna, Paulina,Jaworska, Marcelina,Gajecka, Marzena,Bartl, Franz,Przybylski, Piotr
, p. 96 - 104 (2019)
New rifamycin congeners (1-33) with incorporated amine and hydrazone substituents leading to lipophilic and/or basic nature and altered rigidity of modified C(3) arm were synthesized and structurally characterized in detail. NMR spectroscopic studies at d
